Status:
COMPLETED
French Travelers' Knowledge of Risk of Acquiring ESBL-PE
Lead Sponsor:
CHU de Reims
Conditions:
Travel Medicine
Eligibility:
All Genders
18+ years
Brief Summary
Since it is not routine practice in France to raise public awareness about the risk of acquiring multidrug resistant Enterobacteriaceae (MRE) during international travel, the investigators aimed to de...
Detailed Description
Since it is not routine practice in France to raise public awareness about the risk of acquiring multidrug resistant Enterobacteriaceae (MRE) during international travel, The investigators aimed to as...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Adult travellers who attended the consultation for travel medicine and international vaccination in Reims University Hospital
- Adult who completed the questionnaire
Exclusion
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
191 Patients enrolled
Trial Details
Trial ID
NCT03339947
Start Date
January 1 2016
End Date
June 1 2016
Last Update
November 13 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Damien JOLLY
Reims, France